Arkolith/Insider Trading/SRPT/Form 4

Rodino-Klapac Louise

Head of R&D, CSOSarepta Therapeutics, Inc. (SRPT) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Tax withholding(F)924$100.13$93K79K
Mar 10, 2025Grant(A)8K——85K
Mar 10, 2025Tax withholding(F)3K$100.13$254K76K
Mar 7, 2025Option exercise(M)6K——80K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2025Grant(A)17K—$017K
Mar 7, 2025Option exercise(M)6K—$00

Transaction Codes

F
Shares withheld for taxes
A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-037523) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML